Incidence, Risk Factors and Treatment Response in Patients with Chronic Graft versus-Host Disease after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

被引:0
|
作者
Rivera, Daniel [1 ]
Lopez Corral, Lucia [1 ]
Kwon, Mi [2 ]
Yanez, Lucrecia [3 ]
Pascual Cascon, Maria Jesus [4 ]
Cabrero, Monica [1 ]
Champ, Diana [2 ]
Garcia-Avila, Sara [3 ]
Gallardo Morillo, Anabel [4 ]
Perez, Estefania [1 ]
Balsalobre, Pascual [2 ]
Colorado, Mercedes [3 ]
Garcia Sola, Abel [4 ]
Martin, Ana [1 ]
Luis Diez, Jose [2 ]
Bermudez, Arancha [3 ]
Galloso, Jorge [2 ]
Dolores Caballero, Maria [1 ]
机构
[1] Hosp Univ Salamanca, IBSAL, Salamanca, Spain
[2] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[3] Hosp Univ Marques de Valdecilla, Santander, Spain
[4] Hosp Reg Malaga, Malaga, Spain
来源
关键词
Haploidentical stem cell transplantation; Chronic graft versus-host disease; Hematopoietic stem cell transplantation;
D O I
10.1016/j.clml.2018.07.261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SCT-020
引用
收藏
页码:S304 / S304
页数:1
相关论文
共 50 条
  • [31] Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis
    D. Ruttens
    P. Philippet
    G. Bucciol
    I. Meyts
    Journal of Clinical Immunology, 2023, 43 : 1758 - 1765
  • [32] Graft versus host disease after liver transplantation: Incidence, risk factors and outcomes.
    Nonthasoot, Bunthoon
    Hong, Johnny C.
    Ghobrial, Rafik M.
    Collins, Thomas E.
    Farmer, Douglas G.
    Reed, Elaine
    Busuttil, Ronald W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 165 - 165
  • [33] Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide: Does Graft Source Matter?
    Devine, Steven M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) : 2984 - +
  • [34] Incidence and Risk Factors for Fatal Graft-versus-host Disease After Liver Transplantation
    Kitajima, Toshihiro
    Henry, Matthew
    Ivanics, Tommy
    Yeddula, Sirisha
    Collins, Kelly
    Rizzari, Michael
    Yoshida, Atsushi
    Abouljoud, Marwan S.
    Nagai, Shunji
    Moonka, Dilip
    TRANSPLANTATION, 2021, 105 (12) : 2571 - 2578
  • [35] A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
    Morozova, Elena Vladislavovna
    Barabanshikova, Maria Vladimirovna
    Moiseev, Ivan Sergeevich
    Shakirova, Alena Igorevna
    Barhatov, Ildar Munerovich
    Ushal, Inna Edvardovna
    Rodionov, Gennadij Georgievich
    Moiseev, Sergey Ivanovich
    Surkova, Elena Arkadjevna
    Lapin, Sergey Vladimirovich
    Vlasova, Julia Jurjevna
    Rudakova, Tatjana Alexandrovna
    Darskaya, Elena Igorevna
    Baykov, Vadim Valentinovich
    Alyanski, Alksandr Leonidovich
    Bondarenko, Sergey Nikolaevich
    Afanasyev, Boris Vladimirovich
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 158 - 165
  • [36] Post-Transplantation CyclophosphamideBased Graft-versus-Host Disease Prophylaxis
    Bolanos-Meade, J.
    Hamadani, M.
    Wu, J.
    Al Malki, M. M.
    Martens, M. J.
    Runaas, L.
    Elmariah, H.
    Rezvani, A. R.
    Gooptu, M.
    Larkin, K. T.
    Shaffer, B. C.
    El Jurdi, N.
    Loren, A. W.
    Solh, M.
    Hall, A. C.
    Alousi, A. M.
    Jamy, O. H.
    Perales, M. -A.
    Yao, J. M.
    Applegate, K.
    Bhatt, A. S.
    Kean, L. S.
    Efebera, Y. A.
    Reshef, R.
    Clark, W.
    DiFronzo, N. L.
    Leifer, E.
    Horowitz, M. M.
    Jones, R. J.
    Holtan, S. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2338 - 2348
  • [37] Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
    Queralt Salas, Maria
    Atenafu, Eshetu G.
    Datt Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis
    Michelis, Fotios, V
    Gerbitz, Armin
    Howard Lipton, Jeffrey
    Mattsson, Jonas
    Kumar, Rajat
    Viswabandya, Auro
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 428.e1 - 428.e9
  • [38] Identifying Risk Factors for Acute and Chronic Graft-Versus-Host Disease in TReplete HLA-Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide
    Baron, Jimena
    Ridgeway, Michelle
    Zhang, Xu
    Bashey, Asad
    Solomon, Scott R.
    Holland, H. Kent
    Morris, Lawrence E.
    Solh, Melhem M.
    BLOOD, 2017, 130
  • [39] Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia
    Srour, Samer A.
    Milton, Denai R.
    Bashey, Asad
    Karduss-Urueta, Amado
    Al Malki, Monzr M.
    Romee, Rizwan
    Solomon, Scott
    Nademanee, Auayporn
    Brown, Stacey
    Slade, Michael
    Perez, Rosendo
    Rondon, Gabriela
    Forman, Stephan J.
    Champlin, Richard E.
    Kebriaei, Partow
    Ciurea, Stefan O.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 318 - 324
  • [40] Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
    Lin, Andrew
    Flynn, Jessica
    DeRespiris, Lauren
    Figgins, Bradley
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony
    Devlin, Sean M.
    Cho, Christina
    Tamari, Roni
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Seo, Susan K.
    Shaffer, Brian
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):